Rakesh Kumar, Vice President of Projects, Haematology R&D at AstraZeneca, shared a post on LinkedIn:
“Accounting for ~6% of total cancer cases and ~7% of cancer-related deaths globally, blood cancers have a significant impact worldwide.
Behind each diagnosis is a person – supported by caregivers, families and communities – highlighting the urgent need to continue advancing research and improving care.
At the European Hematology Association (EHA) Congress, AstraZeneca is sharing data from 25+ abstracts, spanning multiple blood cancers. Together, these insights help deepen our understanding of disease and inform the future of care.
Read more on how we’re contributing to research that may help ensure blood cancer is better treated and outcomes continue to improve over time.”
Other articles featuring Rakesh Kumar on OncoDaily.
